2024年11月12日早盘,医脉通(02192.HK)股价出现大涨行情,截至9点40分已大涨10.77%。该股自开盘以来一路震荡攀升,最高上涨幅度触及13.64%。大涨可谓令投资者惊喜,背后原因值得分析。
根据相关信息,南向资金近期加码布局医脉通已连续7日,11日单日净买入15.95万股,累计持股占流通股份3.12%,体现出资金对该股较为乐观的期望。此外,公司最新公布的财报数据也显示出良好的业绩表现,年度营收2.67亿港元,净利润达1.61亿港元,每股收益0.22港元。这一可观的成绩加之行业前景一片光明,获得了100%买入评级机构的青睐。
综上所述,可以初步判断本次医脉通暴涨主因或为资金流入效应增强以及投资者对于公司业绩及未来发展预期持有乐观态度。不过,中长期来看,市场仍存在不确定因素,投资者切勿盲目跟风,谨慎操作为上。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.